Bactericidal/permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 52, Issue 5, 2015, Pages 525-534

  Britto, Clemente J ^a   Cohn, Lauren ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway epithelium; BPIFA1; Host protection; Inflammation; SPLUNC1

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN FOLD CONTAINING FAMILY MEMBER A1; PALATE LUNG AND NASAL EPITHELIUM CLONE PROTEIN; PROTEIN; UNCLASSIFIED DRUG; AUTACOID; BPIFA1 PROTEIN, HUMAN; GLYCOPROTEIN; PHOSPHOPROTEIN;

AIRWAY SURFACE LIQUID; ANTIMICROBIAL ACTIVITY; ARTICLE; ASTHMA; CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; FIBROSING ALVEOLITIS; HUMAN; IMMUNOMODULATION; ION TRANSPORT; LUNG CANCER; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LUNG DISEASE; METABOLISM; MICROBIOLOGY; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LUNG DISEASES; PHOSPHOPROTEINS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84929468871     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0297RT     Document Type: Article

References (88)

1. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011;216:322-333.
2. Waterer GW. Airway defense mechanisms. Clin Chest Med 2012;33:199-209.
3. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 2010;135:1-11.
4. Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun 2006;74:4708-4714.
5. Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human bpi and two bound phospholipids at 2.4 angstrom resolution. Science 1997;276:1861-1864.
6. Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA 2002;99:3902-3907.
7. Bingle CD, Bingle L, Craven CJ. Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family. Biochem Soc Trans 2011;39:961-965.
8. Bingle CD, Seal RL, Craven CJ. Systematic nomenclature for the plunc/psp/bsp30/smgb proteins as a subfamily of the BPI fold-containing superfamily. Biochem Soc Trans 2011;39:977-983.
9. Barnes FA, Bingle L, Bingle CD. Pulmonary genomics, proteomics, and pluncs. Am J Respir Cell Mol Biol 2008;38:377-379.
10. HUGO Gene Nomenclature Committee at the European Bioinformatics Institute. Symbol Report: BPIFA1. Cambridge, UK; 2014 [accessed 2014 Mar. 14]. Available from: http://www.genenames.org/cgi-bin/gene-symbol-report?hgnc-id=HGNC:15749
11. Weston WM, Le Clair EE, Trzyna W, McHugh KM, Nugent P, Lafferty CM, Ma L, Tuan RS, Greene RM. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J Biol Chem 1999;274:13698-13703.
12. Scheetz TE, Zabner J, Welsh MJ, Coco J, Eyestone Mde F, Bonaldo M, Kucaba T, Casavant TL, Soares MB, McCray PB Jr. Large-scale gene discovery in human airway epithelia reveals novel transcripts. Physiol Genomics 2004;17:69-77.
13. Shultz MA, Zhang L, Gu YZ, Baker GL, Fannuchi MV, Padua AM, Gurske WA, Morin D, Penn SG, Jovanovich SB, et al. Gene expression analysis in response to lung toxicants: I. Sequencing and microarray development. Am J Respir Cell Mol Biol 2004;30:296-310.
14. Ghafouri B, Stahlbom B, Tagesson C, Lindahl M. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2002;2:112-120.
15. Genter MB, Van Veldhoven PP, Jegga AG, Sakthivel B, Kong S, Stanley K, Witte DP, Ebert CL, Aronow BJ. Microarray-based discovery of highly expressed olfactory mucosal genes: potential roles in the various functions of the olfactory system. Physiol Genomics 2003;16:67-81.
16. Boon K, Bailey NW, Yang J, Steel MP, Groshong S, Kervitsky D, Brown KK, Schwarz MI, Schwartz DA. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009;4:e5134.
17. Bingle CD, Bingle L. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta 2000;1493:363-367.
18. Di YP, Harper R, Zhao Y, Pahlavan N, Finkbeiner W, Wu R. Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 2003;278:1165-1173.
19. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, Zhou M, Zhu S, Zhou J, Qian J, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 2003;38:80-90.
20. Hobbs CA, Blanchard MG, Alijevic O, Tan CD, Kellenberger S, Bencharit S, Cao R, Kesimer M, Walton WG, Henderson AG, et al. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 2013;305:L990-L1001.
21. Di YP. Functional roles of SPLUNC1 in the innate immune response against gram-negative bacteria. Biochem Soc Trans 2011;39:1051-1055.
22. Garland AL, Walton WG, Coakley RD, Tan CD, Gilmore RC, Hobbs CA, Tripathy A, Clunes LA, Bencharit S, Stutts MJ, et al. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci USA 2013;110:15973-15978.
23. Campos MA, Abreu AR, Nlend MC, Cobas MA, Conner GE, Whitney PL. Purification and characterization of PLUNC from human tracheobronchial secretions. Am J Respir Cell Mol Biol 2004;30:184-192.
24. Ghafouri B, Kihlstrom E, Stahlbom B, Tagesson C, Lindahl M. Plunc (palate, lung and nasal epithelial clone) proteins in human nasal lavage fluid. Biochem Soc Trans 2003;31:810-814.
25. Ghafouri B, Irander K, Lindbom J, Tagesson C, Lindahl M. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J Proteome Res 2006;5:330-338.
26. Ghafouri B, Kihlstrom E, Tagesson C, Lindahl M. Plunc in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 2004;1699:57-63.
27. Zhou HD, Li XL, Li GY, Zhou M, Liu HY, Yang YX, Deng T, Ma J, Sheng SR. Effect of SPLUNC1 protein on the pseudomonas aeruginosa and epstein-barr virus. Mol Cell Biochem 2008;309:191-197.
28. Zhou HD, Wu MH, Shi L, Zhou M, Yang YX, Zhao J, Deng T, Li XL, Sheng SR, Li GY. Effect of growth inhibition of the secretory protein SPLUNC1 on Pseudomonas aeruginosa [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006;31:464-469.
29. Tsou YA, Huang HJ, Lin WW, Chen CY. Investigation of anti-infection mechanism of lactoferricin and splunc-1. Evid Based Complement Alternat Med 2014;2014:907028.
30. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 2006;43:1864-1871.
31. Britto CJ, Liu Q, Curran DR, Patham B, Dela Cruz CS, Cohn L. Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity. Am J Respir Cell Mol Biol 2013;48:717-724.
32. Bingle L, Bingle CD. Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. Biochem Soc Trans 2011;39:1023-1027.
33. Andrault JB, Gaillard I, Giorgi D, Rouquier S. Expansion of the BPI family by duplication on human chromosome 20: characterization of the RY gene cluster in 20q11.21 encoding olfactory transporters/antimicrobial-like peptides. Genomics 2003;82:172-184.
34. Sung YK, Moon C, Yoo JY, Moon C, Pearse D, Pevsner J, Ronnett GV. Plunc, a member of the secretory gland protein family, is upregulated in nasal respiratory epithelium after olfactory bulbectomy. J Biol Chem 2002;277:12762-12769.
35. Le Clair EE, Nguyen L, Bingle L, MacGowan A, Singleton V, Ward SJ, Bingle CD. Genomic organization of the mouse plunc gene and expression in the developing airways and thymus. Biochem Biophys Res Commun 2001;284:792-797.
36. Leclair EE. Four BPI (bactericidal/permeability-increasing protein)-like genes expressed in the mouse nasal, oral, airway and digestive epithelia. Biochem Soc Trans 2003;31:801-805.
37. Garcia-Caballero A, Rasmussen JE, Gaillard E, Watson MJ, Olsen JC, Donaldson SH, Stutts MJ, Tarran R. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci USA 2009;106:11412-11417.
38. Bingle L, Cross SS, High AS, Wallace WA, Devine DA, Havard S, Campos MA, Bingle CD. SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype. J Pathol 2005;205:491-497.
39. Vargas PA, Speight PM, Bingle CD, Barrett AW, Bingle L. Expression of PLUNC family members in benign and malignant salivary gland tumours. Oral Dis 2008;14:613-619.
40. Zhou HD, Fan SQ, Zhao J, Huang DH, Zhou M, Liu HY, Zeng ZY, Yang YX, Huang H, Li XL, et al. Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol 2006;125:315-324.
41. Vitorino R, Lobo MJ, Ferrer-Correira AJ, Dubin JR, Tomer KB, Domingues PM, Amado FM. Identification of human whole saliva protein components using proteomics. Proteomics 2004;4:1109-1115.
42. Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T. Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 2002;169:6985-6991.
43. Lindahl M, Stahlbom B, Tagesson C. Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight. Electrophoresis 2001;22:1795-1800.
44. Casado B, Pannell LK, Iadarola P, Baraniuk JN. Identification of human nasal mucous proteins using proteomics. Proteomics 2005;5:2949-2959.
45. Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M, Yokouchi H, Ozaki K, Monden M, Tanigami A. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Int J Cancer 2001;91:433-437.
46. Bingle CD, Craven CJ. Comparative analysis of the PLUNC (palate, lung and nasal epithelium clone) protein families. Biochem Soc Trans 2003;31:806-809.
47. Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, Campos MA, Bingle CD. Differential epithelial expression of the putative innate immune molecule splunc1 in cystic fibrosis. Respir Res 2007;8:79.
48. Bartlett JA, Hicks BJ, Schlomann JM, Ramachandran S, Nauseef WM, McCray PB Jr. PLUNC is a secreted product of neutrophil granules. J Leukoc Biol 2008;83:1201-1206.
49. Krasity BC, Troll JV, Weiss JP, McFall-Ngai MJ. LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism. Biochem Soc Trans 2011;39:1039-1044.
50. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against gram-negative bacteria. Biochem Soc Trans 2003;31:785-790.
51. Sayeed S, Nistico L, St Croix C, Di YP. Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect Immun 2013;81:285-291.
52. Liu Y, Di ME, Chu HW, Liu X, Wang L, Wenzel S, Di YP. Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice. J Immunol 2013;191:4259-4268.
53. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, et al. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J Immunol 2007;179:3995-4002.
54. Chu HW, Gally F, Thaikoottathil J, Janssen-Heininger YM, Wu Q, Zhang G, Reisdorph N, Case S, Minor M, Smith S, et al. SPLUNC1 regulation in airway epithelial cells: role of toll-like receptor 2 signaling. Respir Res 2010;11:155.
55. Gally F, Di YP, Smith SK, Minor MN, Liu Y, Bratton DL, Frasch SC, Michels NM, Case SR, Chu HW. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am J Pathol 2011;178:2159-2167.
56. Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, Leikauf GD, Kolls JK, Di YP. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol 2011;187:382-390.
57. McGillivary G, Bakaletz LO. The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway. PLoS One 2010;5:e13224.
58. Liu Y, Bartlett JA, Di ME, Bomberger JM, Chan YR, Gakhar L, Mallampalli RK, McCray PB Jr, Di YP. SPLUNC1/BPIFA1 contributes to pulmonary host defense against klebsiella pneumoniae respiratory infection. Am J Pathol 2013;182:1519-1531.
59. Gakhar L, Bartlett JA, Penterman J, Mizrachi D, Singh PK, Mallampalli RK, Ramaswamy S, McCray PB Jr. PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 2010;5:e9098.
60. Gross CA, Bowler RP, Green RM, Weinberger AR, Schnell C, Chu HW. Beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells. BMC Pulm Med 2010;10:30.
61. Di YP, Tkach AV, Yanamala N, Stanley S, Gao S, Shurin MR, Kisin ER, Kagan VE, Shvedova A. Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes. Am J Respir Cell Mol Biol 2013;49:759-767.
62. Bingle CD, Le Clair EE, Havard S, Bingle L, Gillingham P, Craven CJ. Phylogenetic and evolutionary analysis of the plunc gene family. Protein Sci 2004;13:422-430.
63. Tarran R, Redinbo MR. Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration. Int J Biochem Cell Biol 2014;52:130-135.
64. Rollins BM, Garcia-Caballero A, Stutts MJ, Tarran R. SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes. Channels (Austin) 2010;4:255-259.
65. Gaillard EA, Kota P, Gentzsch M, Dokholyan NV, Stutts MJ, Tarran R. Regulation of the epithelial Na1 channel and airway surface liquid volume by serine proteases. Pflugers Arch 2010;460:1-17.
66. Wright PL, Yu J, Di YP, Homer RJ, Chupp G, Elias JA, Cohn L, Sessa WC. Epithelial reticulon 4b (Nogo-b) is an endogenous regulator of Th2-driven lung inflammation. J Exp Med 2010;207:2595-2607.
67. Thaikoottathil JV, Martin RJ, Di PY, Minor M, Case S, Zhang B, Zhang G, Huang H, Chu HW. SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice. Am J Respir Cell Mol Biol 2012;47:253-260.
68. Chen P, Guo X, Zhou H, Zhang W, Zeng Z, Liao Q, Li X, Xiang B, Yang J, Ma J, et al. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1. PLoS One 2013;8:e56929.
69. Thaikoottathil J, Chu HW. MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells. Mol Immunol 2011;49:415-422.
70. Jiang D, Nelson ML, Gally F, Smith S, Wu Q, Minor M, Case S, Thaikoottathil J, Chu HW. Airway epithelial NF-kB activation promotes Mycoplasma pneumoniae clearance in mice. PLoS ONE 2012;7:e52969.
71. Jiang D, Persinger R, Wu Q, Gross A, Chu HW. a1-Antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice. Respir Res 2013;14:122.
72. Jiang D, Wenzel SE, Wu Q, Bowler RP, Schnell C, Chu HW. Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria. PLoS One 2013;8:e64689.
73. Fornander L, Graff P, Wahlen K, Ydreborg K, Flodin U, Leanderson P, Lindahl M, Ghafouri B. Airway symptoms and biological markers in nasal lavage fluid in subjects exposed to metalworking fluids. PLoS One 2013;8:e83089.
74. Irander K, Borres MP, Ghafouri B. The effects of physical exercise and smoking habits on the expression of SPLUNC1 in nasal lavage fluids from allergic rhinitis subjects. Int J Pediatr Otorhinolaryngol 2014;78:618-622.
75. Tsou YA, Chen CM, Lin TC, Hu FW, Tai CJ, Chen HC, Yeh TH, Harn HJ, Tsai MH, Jan CI. Decreased SPLUNC1 expression is associated with Pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgery. Laryngoscope 2013;123:845-851.
76. Steiling K, Kadar AY, Bergerat A, Flanigon J, Sridhar S, Shah V, Ahmad QR, Brody JS, Lenburg ME, Steffen M, et al. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS ONE 2009;4:e5043.
77. Roxo-Rosa M, Da Costa G, Luider TM, Scholte BJ, Coelho AV, Amaral MD, Penque D. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics 2006;6:2314-2325.
78. Mitas M, Cole DJ, Hoover L, Fraig MM, Mikhitarian K, Block MI, Hoffman BJ, Hawes RH, Gillanders WE, Wallace MB. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem 2003;49:312-315.
79. Cheng M, Chen Y, Yu X, Tian Z, Wei H. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary nonsmall cell lung cancer. BMC Cancer 2008;8:156.
80. Mitas M, Hoover L, Silvestri G, Reed C, Green M, Turrisi AT, Sherman C, Mikhitarian K, Cole DJ, Block MI, et al. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn JMD 2003;5:237-242.
81. Katseli A, Maragos H, Nezos A, Syrigos K, Koutsilieris M. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers. Clin Lung Cancer 2013;14:513-520.
82. Tang Y, Xu L. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma. J Exp Clin Cancer Res 2013;32:37.
83. Benlloch S, Galbis-Caravajal JM, Alenda C, Peiro FM, Sanchez-Ronco M, Rodriguez-Paniagua JM, Baschwitz B, Rojas E, Massuti B. Expression of molecular markers in mediastinal nodes from resected stage I nonsmall-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases. Ann Oncol 2009;20:91-97.
84. Li J, Shi SB, Shi WL, Wang Y, Yu LC, Zhu LR, Ge LP. Lunx mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer. Transl Res 2014;163:27-35.
85. Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, Wu M, Zhou M, Shen S, Li X, et al. Microrna-141 is involved in a nasopharyngeal carcinomarelated genes network. Carcinogenesis 2010;31:559-566.
86. He Y, Zhou G, Zhai Y, Dong X, Lv L, He F, Yao K. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet 2005;42:172-176.
87. Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, Muller D, Marchal P, Zhao C, Melle D, et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2003;89:1940-1949.
88. Gonzalez-Arriagada WA, Santos-Silva AR, Ito FA, Vargas PA, Speight PM, Bingle L, Lopes MA. Expression pattern of PLUNC proteins as an auxiliary tool for the diagnosis of high-grade mucoepidermoid carcinoma of the salivary gland. J Oral Pathol Med 2012;41:589-597.